Expand AGLE Menu

AGLE Stock Summary and Trading Ideas (Aeglea Biotherapeutics | NASDAQ:AGLE)

Charts for Today's Stock Price and Implied Volatility in Aeglea Biotherapeutics


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AGLE by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Aeglea Biotherapeutics (AGLE) Frequently Asked Questions

What does Aeglea Biotherapeutics do?

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases. The company competes in the segments of the pharmaceutical, biotechnology and other related markets that address rare genetic diseases.

What symbol and exchange does Aeglea Biotherapeutics stock trade?

Aeglea Biotherapeutics trades on the NASDAQ stock market under the symbol AGLE.

What is Aeglea Biotherapeutics stock price doing today?

As of September 27, 2023, AGLE stock price climbed to $11.49 with 14,484 million shares trading.

What is Aeglea Biotherapeutics's Beta?

AGLE has a beta of 1.37, meaning it tends to be more sensitive to market movements. AGLE has a correlation of 0.02 to the broad based SPY ETF.

How much is Aeglea Biotherapeutics worth?

AGLE has a market cap of $46.51 million. This is considered a Sub-Micro Cap stock.

How much money does Aeglea Biotherapeutics make?

Last quarter Aeglea Biotherapeutics reported $688,000 in Revenue and -$41.50 earnings per share. This beat revenue expectation by $488,000 and missed earnings estimates by -$37.75.

What is the highest and lowest price Aeglea Biotherapeutics traded in the last 3 year period?

In the last 3 years, AGLE stock traded as high as $247.50 and as low as $2.66.

What are the top ETFs holding Aeglea Biotherapeutics?

The top ETF exchange traded funds that AGLE belongs to (by Net Assets): VXF, DFAC.

Is Aeglea Biotherapeutics (AGLE) a good investment?

AGLE has underperformed the market in the last year with a price return of +1.1% while the SPY ETF gained +18.7%. However, in the short term, AGLE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +21.3% vs -0.9% return in SPY. But in the last 2 weeks, AGLE shares have been beat by the market, returning -17.0% compared to an SPY return of -4.1%.

What is the support and resistance for Aeglea Biotherapeutics (AGLE) stock price?

AGLE support price is $10.15 and resistance is $12.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGLE stock will trade within this expected range on the day.